Atıf İçin Kopyala
Coban E., Sari R., Özdoğan M., Akçit F.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, cilt.113, sa.1, ss.35-37, 2005 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
113
Sayı:
1
-
Basım Tarihi:
2005
-
Doi Numarası:
10.1055/s-2004-830524
-
Dergi Adı:
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.35-37
-
Anahtar Kelimeler:
impaired fasting glucose, fibrinogen, D-dimer, cardiovascular risk, ISCHEMIC-HEART-DISEASE, RISK-FACTOR, CARDIOVASCULAR-DISEASE, MORTALITY, THROMBOGENESIS, TOLERANCE, DEATH, MEN
-
Akdeniz Üniversitesi Adresli:
Evet
Özet
Background: Cardiovascular risk associated with impaired fasting glucose has been examined in various studies with conflicting results. During the last 10 years, several risk markers for atherosclerosis such as fibrinogen and D-dimer have been identified. The present study was designed to evaluate plasma fibrinogen and D-dimer levels in patients with impaired fasting glucose compared with normal subjects and those with type 2 diabetes mellitus.